(Q40753318)

23 September 2017

1 reference

title

CCK, schizophrenia, and anxiety. CCK-B antagonists inhibit the activity of brain dopamine neurons (English)

1 reference

23 September 2017

1 reference

Rasmussen K

1

1 reference

PubMed ID

8185172

23 September 2017

language of work or name

English

0 references

publication date

1 March 1994

1 reference

Annals of the New York Academy of Sciences

23 September 2017

1 reference

23 September 2017

713

1 reference

23 September 2017

300-311

1 reference

Implications of normal brain development for the pathogenesis of schizophrenia

23 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB44078.X

Dopamine in schizophrenia: a review and reconceptualization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB44078.X

Cholecystokinin-dopamine interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB44078.X

Microinjection of cholecystokinin into the rat ventral tegmental area potentiates dopamine-induced hypolocomotion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB44078.X

Quinazolinone cholecystokinin-B receptor ligands.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB44078.X

Cholecystokinin (CCK) and schizophrenia: the selective CCKB antagonist LY262691 decreases midbrain dopamine unit activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB44078.X

Acute and chronic haloperidol treatment: Comparison of effects on nigral dopaminergic cell activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB44078.X

Comparison of the effects of the cholecystokinin-B receptor antagonist, PD 134308, and the cholecystokinin-A receptor antagonist, L-364,718, on dopamine neuronal activity in the substantia nigra and ventral tegmental area

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB44078.X

Firing properties of substantia nigra dopaminergic neurons in freely moving rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB44078.X

Chloral hydrate anesthesia alters the responsiveness of identified midbrain dopamine neurons to dopamine agonist administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB44078.X

Anesthetic influences on the basal activity and pharmacological responsiveness of nigrostriatal dopamine neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB44078.X

Low doses of gamma-hydroxybutyric acid stimulate the firing rate of dopaminergic neurons in unanesthetized rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB44078.X

The behavioural properties of CI-988, a selective cholecystokininB receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB44078.X

Cholecystokinin tetrapeptide induces panic-like attacks in healthy volunteers. Preliminary findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB44078.X

Cholecystokinin-4 and panic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB44078.X

Enhanced sensitivity to cholecystokinin tetrapeptide in panic disorder. Clinical and behavioral findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB44078.X

Evaluation of the effects of PD 134308 (CI-988), A CCK-B antagonist, on the punished responding of squirrel monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB44078.X

'Anxiolytic' effect of CCK-antagonists on plus-maze behavior in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB44078.X

Psychological stress increases dopamine turnover selectively in mesoprefrontal dopamine neurons of rats: reversal by diazepam

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB44078.X

Recent Stressful Life Events and Episodes of Schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB44078.X

Receptor selectivity of cholecystokinin effects on mesoaccumbens dopamine neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB44078.X

Differentiation of central cholecystokinin receptor binding sites using the non-peptide antagonists MK-329 and L-365,260.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB44078.X

Functional role of brain CCK receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB44078.X

Inhibition of A9 and A10 dopamine cells by the cholecystokinin-B antagonist LY262691: mediation through feedback pathways from forebrain sites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB44078.X

The neostriatal mosaic: multiple levels of compartmental organization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB44078.X

The precise localization of nigral afferents in the rat as determined by a retrograde tracing technique

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB44078.X

Prefrontal cortical efferents in the rat synapse on unlabeled neuronal targets of catecholamine terminals in the nucleus accumbens septi and on dopamine neurons in the ventral tegmental area

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB44078.X

Ventral tegmental (A10) system: neurobiology. 1. Anatomy and connectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB44078.X

10.1111/J.1749-6632.1994.TB44078.X

21 January 2018

Identifiers

DOI

1 reference

23 September 2017

1 reference

PubMed ID

8185172